{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:04:20Z","timestamp":1789646660291,"version":"4.0.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background &amp; objectives:<\/jats:title>\n                    <jats:p>\n                      The human blood parasite\n                      <jats:italic toggle=\"yes\">Leishmania donovani<\/jats:italic>\n                      causes visceral leishmaniasis or grayish discoloration of the skin (black fever\/kala-azar). Antitumor drugs such as daunorubicin and etoposide can help to treat such diseases. The computational approach is used to find a better interaction of drugs with the active site of the protein and help to design new drugs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      In this study, we have optimized two antitumor drugs, daunorubicin and etoposide. We studied frontier molecular orbitals, electrostatic potential (MEP) maps, and the natural bond order analysis of these anticancer drugs, followed by molecular docking with\n                      <jats:italic toggle=\"yes\">Leishmania donovani<\/jats:italic>\n                      protein.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The three-dimensional structure of MapK from\n                      <jats:italic toggle=\"yes\">Leishmania donovani<\/jats:italic>\n                      is LDBPK-331470. Our computational calculations reveal that daunorubicin and etoposide drugs can have an affinity with MapK from\n                      <jats:italic toggle=\"yes\">Leishmania donovani<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation &amp; conclusion:<\/jats:title>\n                    <jats:p>\n                      Our study predicted that both daunorubicin and etoposide could have a similar affinity with the protein (UvrD)\n                      <jats:italic toggle=\"yes\">Leishmania donovani<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jvbd.jvbd_174_23","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T03:00:38Z","timestamp":1706583638000},"page":"369-375","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Molecular docking of daunorubicin and etoposide drugs against Leishmania donovani: A theoretical study"],"prefix":"10.4103","volume":"61","author":[{"given":"Afnan Mohammed","family":"Shakoori","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemah","family":"Alhakami","sequence":"additional","affiliation":[{"name":"Genetics and Human Genetics, Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadir","family":"Sindi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej Yahya","family":"Alyahyawi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha Abdullah","family":"Alhazzaa","sequence":"additional","affiliation":[{"name":"Basic Sciences Department, College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,21]]},"reference":[{"key":"R1-20240921","first-page":"1","article-title":"Leishmaniasis: a review","author":"Torres-Guerrero","year":"2005","journal-title":"F1000Res"},{"issue":"3","key":"R2-20240921","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","article-title":"The increase in risk factors for leishmaniasis worldwide","volume":"95","author":"Desjeux","year":"2001","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"R3-20240921","first-page":"1","article-title":"High-risk spatiotemporal patterns of cutaneous leishmaniasis: a nationwide study in Iran from 2011 to 2020","volume":"49","author":"Firouraghi","year":"2023","journal-title":"Infect Di Poverty"},{"key":"R4-20240921","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41598-023-28139-5","article-title":"Epidemiological, clinical and hematological profiles of visceral leishmaniasis among patients visiting Tefera Hailu Memorial Hospital, Northeast Ethiopia: a 4 year retrospective study","volume":"13","author":"Debash","year":"2023","journal-title":"Sci Rep"},{"key":"R5-20240921","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pt.2005.11.004","article-title":"Risk factors in the spread of leishmaniases: towards integrated monitoring?","volume":"22","author":"Dujardin","year":"2006","journal-title":"Trends Parasitol"},{"key":"R6-20240921","first-page":"1","article-title":"Epidemiological features and spatial-temporal clustering of visceral leishmaniasis in mainland China from 2019 to 2021","author":"Li","year":"2022","journal-title":"Front Microbiol"},{"key":"R7-20240921","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1021\/bi9729099","article-title":"Pre-steady-state analysis of ATP hydrolysis by Saccharomyces cerevisiae DNA topoisomerase II. 1. A DNA-dependent burst in ATP hydrolysis","volume":"37","author":"Harkins","year":"1998","journal-title":"Biochemistry"},{"key":"R8-20240921","doi-asserted-by":"crossref","first-page":"13685","DOI":"10.1073\/pnas.96.24.13685","article-title":"Topoisomerase II drives DNA transport by hydrolysing one ATP","volume":"96","author":"Baird","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R9-20240921","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BCJ20160583","article-title":"Topoisomerases as anticancer targets","volume":"475","author":"Delgado","year":"2018","journal-title":"Biochem J"},{"key":"R10-20240921","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.str.2022.05.009","article-title":"A comprehensive structural analysis of the ATPase domain of human DNA topoisomerase II beta bound to AMPPNP, ADP, and the bisdioxopiperazine, ICRF193","volume":"30","author":"Ling","year":"2022","journal-title":"Structure"},{"key":"R11-20240921","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.1204117","article-title":"Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide","volume":"333","author":"Wu","year":"2011","journal-title":"Science"},{"key":"R12-20240921","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0006-2952(03)00467-2","article-title":"Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro","volume":"66","author":"Mahoney","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"R13-20240921","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pharmthera.2011.07.006","article-title":"Anthracyclines and ellipticines as DNA-damaging anticancer drugs: recent advances","volume":"133","author":"Kizek","year":"2023","journal-title":"Pharmacol Ther"},{"key":"R14-20240921","first-page":"19","article-title":"DNA-intercalators the anthracyclines in drugs affecting growth of tumours","author":"Mross","year":"2006"},{"key":"R15-20240921","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.biomaterials.2011.09.055","article-title":"Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"R16-20240921","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/IJN.S233395","article-title":"Daunorubicin-loaded CdTe QDs conjugated with anti-CD123 mAbs: a novel delivery system for myelodysplastic syndromes treatment","volume":"15","author":"Guo","year":"2020","journal-title":"Int J Nanomed"},{"key":"R18-20240921","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00214-007-0310-x","article-title":"The M06 Suite of Density Functionals for Main Group Thermochemistry, Thermochemical Kinetics, Noncovalent Interactions, Excited States, and Transition Elements: Two New Functionals and Systematic Testing of Four M06-Class Functionals and 12 Other Functionals","volume":"120","author":"Zhao","year":"2008","journal-title":"Theoretical Chemistry accounts"},{"key":"R19-20240921","first-page":"327","article-title":"Ab initio study of solvated molecules: a new implementation of the polarizable continuum model","volume":"255","author":"Cossi","year":"1996","journal-title":"Chem PhysLett"},{"key":"R20-20240921","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comp Chem"},{"key":"R21-20240921","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: A Unified Platform for Automated Protein Structure and Punction Prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat Protoc"},{"key":"R22-20240921","doi-asserted-by":"crossref","first-page":"W593","DOI":"10.1093\/nar\/gkac389","article-title":"PrankWeb 3: Accelerated Ligand-Binding Site Predictions for Experimental and Modelled Protein Structures","volume":"50","author":"Jakubec","year":"2022","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Vector Borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/JVBD.JVBD_174_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:47:07Z","timestamp":1787773627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/JVBD.JVBD_174_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jvbd.jvbd_174_23","relation":{},"ISSN":["0972-9062"],"issn-type":[{"value":"0972-9062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2023-11-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}